To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors
Clinical trial NCT03002493 · COMPLETED
Trial details
- NCT number
- NCT03002493
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.